Feedback on the FDA's February 2006 draft guidance on patient reported outcome (PRO) measures from a developer of PRO measures

Health and Quality of Life Outcomes

Volumn 4, Issue , 2006, Pages

  Bradley, Clare ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; GOOD CLINICAL PRACTICE; HEALTH STATUS; HUMAN; INDIVIDUALIZATION; LINGUISTICS; MEDICAL RESEARCH; METHODOLOGY; OUTCOMES RESEARCH; PATIENT INFORMATION; PRACTICE GUIDELINE; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SELF REPORT; VALIDATION STUDY; VALIDITY;

ATTITUDE TO HEALTH; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; PRODUCT SURVEILLANCE, POSTMARKETING; PSYCHOMETRICS; QUALITY OF LIFE; SELF CONCEPT; SICKNESS IMPACT PROFILE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33750976942     PISSN: 14777525     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-4-78     Document Type: Article

References (41)

1. Bradley C, Lewis KS: Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabet Med 1990, 7:445-451.
2. Bradley C: The Diabetes Treatment Satisfaction Questionnaire: (DTSQ). In Handbook of Psychology and Diabetes: a guide to psychological measurement in diabetes research and practice Edited by: Bradley C Chur. Switzerland: Harwood Academic Publishers; 1994:111-132.
3. Bradley C, Gamsu DS: Guidelines for encouraging psychological well-being: report of a Working Group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St Vincent Declaration Action Programme for Diabetes. Diabet Med 1994, 11:510-516.
4. Bradley C, Speight J: Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev 2002, 18:S64-69.
5. Bradley C, Plowright R, Stewart J, Witthaus E: Diabetes Treatment Satisfaction Questionnaire (change) in English and German evaluated in insulin glargine trials. Diabetologia 2000, 43:A196.
6. Howorka K, Pumprla J, Schlusche C, Wagner-Nosiska D, Schabmann A, Bradley C: Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: Assessment of improvements in treatment satisfaction with a new insulin analogue. Qual Life Res 2001, 9:915-930.
7. Woodcock A, Bradley C: Validation of the HIV treatment satisfaction questionnaire (HIVTSQ). Qual Life Res 2001, 10:517-531.
8. Taback N, Bradley C: Validation of the Genital Herpes Treatment Satisfaction Questionnaire (GHerpTSQ) in Status and Change Versions. Qual Life Res 2006, 15:1043-1052.
9. Barendse SM, Speight J, Bradley C: The Renal Treatment Satisfaction Questionnaire (RTSQ): a measure of satisfaction with treatment for chronic kidney failure. Am J Kidney Dis 2005, 45:572-579.
10. Woodcock A, Plowright R, Kennedy-Martin T, Hirsch A, ffytche T, Bradley C: Development of the new Retinopathy Treatment Satisfaction Questionnaire (RetTSQ). Proceedings of Vision 2005; International Congress Series 2005, 1282:342-346.
11. Taback N, Bradley C: Validation of the Genital Herpes Treatment Satisfaction Questionnaire (GHerpTSQ) in Status and Change Versions. Qual Life Res 2000, 9:332.
12. McMillan CV, Bradley C, Woodcock A, Razvi S, Weaver JU: Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism. Thyroid 2004, 14:916-925.
13. Bradley C: The 12-Item Well-Being Questionnaire: origins, current stage of development, and availability. Diabetes Care 2000, 23:875.
14. Pouwer F, van der Ploeg HM, Ader HJ, Heine RJ, Snoek FJ: The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes. Diabetes Care 1999, 22:2004-2010.
15. Pouwer F, Snoek FJ, Van der Ploeg HM, Ader HJ, Heine RJ: The Well-Being Questionnaire: evidence for a three factor structure with 12 items (W-BQ12). Psychol Med 2000, 30:455-462.
16. Mitchell J, Bradley C: Psychometric evaluation of the 12-item Well-being Questionnaire for use with people with macular disease. Qual Life Res 2001, 10:465-473.
17. McMillan CV, Bradley C, Gibney J, Russell-Jones DL, Sonksen PH: Psychometric properties of two measures of psychological well-being in adult growth hormone deficiency. Health Qual Life Outcomes 2006, 4:16.
18. Riazi A, Bradley C, Barendse S, Ishii H: Development of the Well-being questionnaire short-form in Japanese: the W-BQ12. Health Qual Life Outcomes 2006, 4:40.
19. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R: The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999, 8:79-91.
20. Bradley C: Design of a renal-dependent individualised quality of life questionnaire. Adv Perit Dial 1997, 13:116-120.
21. Woodcock A, Bradley C, Plowright R, ffytche T, Kennedy-Martin T, Hirsch A: The influence of diabetic retinopathy on quality of life: interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL. Patient Educ Couns 2004, 53:365-383.
22. Mitchell J, Bradley C: Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL). Qual Life Res 2004, 13:1163-1175.
23. Mitchell J, Wolffsohn JS, Woodcock A, Anderson SJ, McMillan CV, ffytche T, Rubinstein M, Amoaku W, Bradley C: Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life. Health Qual Life Outcomes 2005, 3:25.
24. McMillan CV, Bradley C, Gibney J, Healy ML, Russell-Jones DL, Sonksen PH: Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency. Clin Endocrinol (Oxf) 2003, 59:467-475.
25. McMillan CV, Bradley C, Giannoulis M, Martin F, Sonksen PH: Preliminary development of a new individualised questionnaire measuring quality of life in older men with age-related hormonal decline: the A-RHDQoL. Health Qual Life Outcomes 2003, 1:51
26. McMillan CV, Honeyford RJ, Datta J, Madge NJ, Bradley C: The development of a new measure of quality of life for young people with diabetes mellitus: the ADDQoL-Teen. Health Qual Life Outcomes 2004, 2:61.
27. McMillan C, Bradley C, Gibney J, Russell-Jones DL, Sonksen PH: Preliminary development of the new individualised HDQoL questionnaire measuring quality of life in adult hypopituitarism. J Eval Clin Pract 2006, 12:501-514.
28. U.S. Food and Drug Administration: 2006D-0044:Guidance for Industry on Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2006 [http://www.fda.gov/ohrms/dockets/dockets/ 06d0044/1.htm].
29. Bradley C: Importance of differentiating health status from quality of life. Lancet 2001, 357:7-8.
30. Group UKPDS: Quality of Life in Type 2 Diabetic Patients Is Affected by Complications But Not by Intensive Policies to Improve Blood Glucose or Blood Pressure Control (UKPDS 37). Diabetes Care 1999, 22:1125-1136.
31. Bradley C, Tamburini M: Not-only-a title. Editorial. Health Qual Life Outcomes 2003, 1:1.
32. Joyce CRB: Requirements for the assessment of individual quality of life. In Quality of Life Following Renal Failure: Psychosocial Challenges Accompanying High Technology Medicine Edited by: McGee HM, Bradley C Chur. Switzerland: Harwood Academic; 1994:43-54.
33. McGee HM, O'Boyle CA, Hickey A, O'Malley KM, Joyce CRB: Assessing the quality of life of the individual: The SEIQoL with a healthy and a gastroenterology unit population. Psychol Med 1991, 21:749-759.
34. Witthaus E, Ashwell SG, Johnston P, Stephens J, Home PD, Bradley C: Quality of life is improved with insulin glargine + lispro compared with NPH insulin + regular human insulin in patients with Type 1 diabetes. Diabetologia 2004, 47:.
35. DAFNE Study Group: Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: the dose adjustment for normal eating (DAFNE) randomised control trial. BMJ 2002, 325:746-749.
36. McMillan C, Bradley C, Gibney J, Russell-Jones D, Sonksen P: Well-being in adult growth hormone deficiency. Health Qual Life Outcomes 2006, 4:16.
37. Polonsky WH: Understanding and Assessing Diabetes-Specific Quality of Life. Diabetes Spectrum 2000, 13:17-22.
38. Garratt AM, Schmidt L, Fitzpatrick R: Patient-assessed health outcome measures for diabetes: a structured review. Diabet Med 2002, 19:1-11.
39. Greenhalgh J, Long AF, Brettle AJ, Grant MJ: Reviewing and selecting outcome measures for use in routine practice. J Eval Clin Pract 1998, 4:339-350.
40. Wee HL, Tan CE, Goh SY, Li SC: Usefulness of the Audit of Diabetes-Dependent Quality of Life (ADDQoL) questionnaire in patients with diabetes in a multi-ethnic Asian country. PharmacoEconomics 2006 in press.
41. Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273:408-412.